Outputs
GlycoCell began in 2024. These are the first published outputs of a growing programme. Some recently completed work may not be shown yet. Before publishing, we assess the need to protect intellectual property and plan how best to take new results forward, including with partners.
Research papers
- 2025Read the paper →
Recent advances in bioconjugate vaccine development
Vaccines 13 (7)
- 2025Read the paper →
A structural basis for the strain-dependent UDP-sugar specificity of glycosyltransferase C from the Limosilactobacillus reuteri accessory secretion system
Acta Crystallographica Section D
- 2025Read the paper →
Modular combinatorial DNA assembly of Group B Streptococcus capsular polysaccharide biosynthesis pathways to expedite the production of novel glycoconjugate vaccines
Vaccines 13 (3): 279
- 2025Read the paper →
Recombinant production platform for Group A Streptococcus glycoconjugate vaccines
npj Vaccines 10
- 2024Read the paper →
Investigation into the efficiency of diverse N-linking oligosaccharyltransferases for glycoengineering using a standardised cell-free assay
Microbial Biotechnology 17 (6)
Talks and engagement
- 2026BioAmass SummitInvited talk
- 2026STEM for Britain, Houses of ParliamentPoster
- 2025UKRI Engineering Biology Mission Hubs and Awards showcasePoster
- 2025UKRI Engineering Biology Mission Hubs webinar seriesGlycoCell session
- 2025Gordon Research Conference on Synthetic BiologyInvited talk
- 2025Japan–UK engineering biology meetingInvited talk
- 2025Synthetic Biology UK 2025Invited talk
- 2025BioIndustry AssociationInvited talk
- 2024SynbiTECH 2024Invited talk
- 2024High Value Biorenewables Network annual meetingInvited talk
- 2024Pioneer Presents: Human Health in a Changing Climate, TeessideInvited talk
- 2024Malaysian Society for Biochemistry and Molecular Biology conferencePlenary lecture
- 2024Biochemical Society, Advances and New Horizons in GlycobiologyTalks
- 2024Pint of Science, ExeterPublic talk